Picture of Biohit Oyj logo

BIOBV Biohit Oyj Share Price

0.000.00%
fi flag iconLast trade - 00:00
TechnologySpeculativeMicro CapHigh Flyer

Momentum

Relative Strength (%)
1m+1.8%
3m+13.88%
6m+10.39%
1yr-8.97%
Volume Change (%)
10d/3m-42.54%
Price vs... (%)
52w High-21.63%
50d MA+2.63%
200d MA+9.15%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value3.21
Price to Tang. Book3.25
Price to Free Cashflow27.47
Price to Sales2.21
EV to EBITDA9.35

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11.86%
Return on Equity6.45%
Operating Margin8.9%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Biohit Oyj EPS forecast chart

Profile Summary

Biohit Oyj is a Finland-based company engaged in the development, manufacture and marketing of diagnostic tests and analysis systems. The Company operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. It provides blood-sample examination based on GastroPanel for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, as well as the ColonView examination for the early detection of fecal occult intestinal bleeding, which indicates a risk of colorectal cancer. The Company’s products are used in hospitals, healthcare centers and research institutions. It operates primarily in Europe and Asia. Furthermore, the Company is a parent of Biohit Healthcare Ltd, Biohit Healthcare Srl, Oy Finio Ab, and Vantaan Hienomekano Oy, among others.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
March 9th, 1988
Public Since
June 18th, 1999
No. of Employees
42
Sector
Office Equipment
Industry
Technology
Exchange
fi flag iconOMX Nordic Exchange - Helsinki
Shares in Issue
15,045,593

BIOBV Share Price Performance

Upcoming Events for BIOBV

FAQ

Or unlock with your email

Or unlock with your email